00-113-032 CI bus Safetybus Gate 2
CI bus Safetybus Gate 2 for a KUKA KRC2 safety path.
System role
Rebuilt from individual evidence
Evidence boundary
The parts catalog identifies the exact reference as a CI bus Safetybus Gate 2. Sits between the KRC2 safety interface and the Safetybus network.
CI bus Safetybus Gate 2 for a KUKA KRC2 safety path. The system placement above is an inference from the documented function and adjacent path.
- Exact reference
- 00-113-032
- Category
- Robotics
- Evidence checked
- 2026-09-11
System role
This section explains what the product does and where it acts in the surrounding system.
- Function
- Routes Safetybus communication between the KRC2 safety interface and the safety network.
- System position
- Sits between the KRC2 safety interface and the Safetybus network.
- Upstream / inputs
- Safety devices provide safety bus traffic to the gateway.
- Downstream / outputs
- The KRC2 safety interface receives routed Safetybus traffic.
- Limitations
- Unknown: Bus node settings, connectors, and supported controller revisions are not stated in the captured catalog.
Evidence ledger
Facts, inferences, and unknowns are kept separate.
Facts
The captured source identifies 00-113-032 as CI bus Safetybus Gate 2.
- www.scribd.com — retrieved 2026-09-11; high confidence
The parts catalog identifies the exact reference as a CI bus Safetybus Gate 2.
- www.scribd.com — retrieved 2026-09-11; high confidence
Inferences
Sits between the KRC2 safety interface and the Safetybus network.
- www.scribd.com — retrieved 2026-09-11; high confidence
Unknowns
Unknown: Bus node settings, connectors, and supported controller revisions are not stated in the captured catalog.
System position diagram
View Mermaid source
flowchart LR; Upstream[Upstream path] --> Part[Referenced part]; Part --> Downstream[Downstream path]View diagram labels
- Nodes
- Upstream path; 00-113-032 part; Downstream path
- Edges
- Documented input; Documented output
Request help with this reference
Provide the exact reference, machine context, and observed symptom so the next review can stay evidence-based.
